在肝细胞癌中,AMD1的预后性,致癌性作用和药物遗传学特征
Youliang Zhou1, Yi Zhou2, Jiabin Hu3
1Department of Medical Insurance, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310015, Zhejiang, China.
Cancer cell international
|December 19, 2024
概括
S-adenosylmethionine脱碳酶1 (AMD1) 促进肝细胞癌 (HCC) 的进展. 下调AMD1抑制HCC细胞生长和入侵,与AMD1相关的风险评分预测患者的预后和治疗反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- S-adenosylmethionine decarboxylase 1 (AMD1) 是一种基因,在肝细胞癌 (HCC) 预后中没有明确的作用.
- 研究AMD1的影响对于理解HCC进展和确定治疗点至关重要.
研究的目的:
- 阐明AMD1在HCC进展和患者结局中的作用.
- 开发基于AMD1和相关基因的HCC的预后和预测模型.
主要方法:
- 对AMD1表达和与临床/免疫学特征相关的TCGA肝脏HCC数据集的分析.
- 在体外实验评估AMD1调制对HCC细胞的功能影响.
- 生物信息学方法包括Cox回归和使用AMD1相关基因 (ARG) 构建风险得分模型.
主要成果:
- 高AMD1表达与HCC的不良结果和不良免疫疗法反应相关.
- 降低AMD1的调控抑制了HCC细胞的增殖,迁移和入侵.
- 一种新的9-ARG风险评分模型有效预测HCC预后和化学抵抗,在队列中得到验证.
结论:
- AMD1是HCC进展的潜在治疗标和生物标志物.
- 开发的AMD1相关风险评分为预测HCC患者预后和治疗响应度提供了有价值的工具.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


